NCI sells majority stake in Herbolistique to Yotta Capital Partners, Ouest Croissance

Reuters2026/07/30 10:47

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

NCI exited its majority stake in dietary supplements maker Laboratoires Herbolistique, selling to Yotta Capital Partners, Ouest Croissance, and other investors.
NCI Dette Privée 1 provided mezzanine debt financing alongside the acquisition financing to support the company’s next growth phase.
Herbolistique was founded in 2002 in La Verrie, France, producing plant-based natural supplements.
NCI entered as majority shareholder in 2021; revenue rose to nearly EUR 15 million from EUR 10 million, headcount increased to 58.
The deal marks the second investment by NCI’s private debt fund, following a transaction with Leader Group.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NCI SAS published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

NCI sells majority stake in Herbolistique to Yotta Capital Partners, Ouest Croissance

You may also like

Crypto prices